Immunogenicity of Different Forms of Middle East Respiratory Syndrome S Glycoprotein

The Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in 2012 during the first Middle East respiratory syndrome (MERS) outbreaks. MERS-CoV causes an acute lower-respiratory infection in humans, with a fatality rate of ~35.5%. Currently, there are no registered vaccines or means...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acta Naturae
Auteurs principaux: Ozharovskaia, T. A., Zubkova, O. V., Dolzhikova, I. V., Gromova, A. S., Grousova, D. M., Tukhvatulin, A. I., Popova, O., Shcheblyakov, D. V., Scherbinin, D. N., Dzharullaeva, A. S., Erokhova, A. S., Shmarov, M. M., Loginova, S. Y., Borisevich, S. V., Naroditsky, B. S., Logunov, D. Y., Gintsburg, A. L.
Format: Artigo
Langue:Inglês
Publié: A.I. Gordeyev 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6475872/
https://ncbi.nlm.nih.gov/pubmed/31024747
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires